Evidence Brief

Reducing severe breathlessness with dronabinol in the group of patients with severe and very severe chronic obstructive pulmonary disease (BONG): a randomised, double-blinded, placebo-controlled, crossover study in an outpatient clinic in Denmark

A new randomized crossover trial will investigate whether dronabinol COPD breathlessness treatment can help patients with severe symptoms. This protocol review examines the study design and clinical context for cannabis medicine in respiratory care.

Read More